The paradox of elevated cortisol with persistent inflammation—and what it reveals about energy production, vitamin D signalling, and the connection between your brain, nervous system, and immune function.

One of the most counterintuitive patterns I encounter in clinical practice involves patients presenting with elevated cortisol alongside unrelenting inflammation, profound fatigue, and immune problems. Conventional thinking suggests that high cortisol should suppress inflammation—after all, cortisol-based medications remain the cornerstone of anti-inflammatory treatment. Yet these individuals continue to experience widespread inflammation despite their adrenal glands working overtime.
The resolution to this apparent contradiction lies not in cortisol production itself, but in cortisol responsiveness—a distinction with profound implications for conditions ranging from chronic fatigue syndrome and long COVID to autoimmune disease and treatment-resistant eczema.

Cortisol Resistance
The clinical picture of chronic inflammation coexisting with elevated cortisol typically reflects cortisol resistance rather than the adrenals simply making too much. This represents a fundamental shift in how we should think about stress hormones in chronic disease. When cortisol fails to switch off inflammatory signals at the cellular level, the brain's stress-signalling centre (the hypothalamus) keeps pushing for more, further driving the 'fight or flight' response and perpetuating the very inflammation cortisol should be resolving.
Understanding this mechanism transforms our treatment approach. Rather than attempting to suppress cortisol output—which would be addressing a compensatory response rather than the underlying problem—we must restore the cellular machinery that allows cortisol to do its intended job.

High cortisol with persistent inflammation suggests cortisol resistance, not cortisol overproduction. The treatment priority shifts from dampening adrenal output to restoring your cells' ability to actually respond to cortisol.

The Mitochondria - Why Your Energy Factories Determine Whether Cortisol Works
Perhaps the most clinically actionable insight from recent research concerns the intimate relationship between mitochondrial function (your cells' energy production) and cortisol signalling. Cortisol's anti-inflammatory effects depend critically on healthy mitochondria—specifically, on their ability to produce a compound called itaconate, which has powerful immune-calming properties.
Itaconate is made inside mitochondria as part of the energy production cycle (the Krebs cycle). It turns out that cortisol actually relies on itaconate to deliver its anti-inflammatory message. When mitochondria aren't functioning well—as commonly occurs in chronic fatigue, post-viral illness, and prolonged stress—itaconate production drops, and cortisol loses its ability to calm inflammation regardless of how much is circulating in your blood.
This creates a self-reinforcing problem: inflammation persists, the brain signals for more cortisol, cortisol rises further, yet the cellular infrastructure required for cortisol to work remains broken. The body mounts an increasingly vigorous stress response while simultaneously losing the ability to translate that response into actual inflammatory control.

Poor mitochondrial function creates functional cortisol resistance. Supporting cellular energy production through targeted nutritional intervention may prove more effective than either cortisol suppression or steroid medications.

Vitamin D - Overlooked Gatekeeper of Cortisol Sensitivity
Vitamin D's role in stress resilience extends far beyond its well-known immune functions. Adequate vitamin D maintains expression of the cortisol receptor—the docking station on cells where cortisol must land to exert its effects. When vitamin D is insufficient, your cells produce fewer of these receptors, meaning cortisol has fewer places to dock and deliver its message. The result is that your cells become less responsive to cortisol even when levels are normal or elevated.
This relationship has significant treatment implications. Vitamin D supplementation has been shown to increase cortisol receptor expression, effectively restoring your cells' sensitivity to cortisol. Additionally, adequate vitamin D status suppresses the production of inflammatory messengers that drive allergic-type and autoimmune-type inflammation.
Tissue-Level Vitamin D 
A critical nuance often missed in clinical assessment concerns the distinction between vitamin D levels measured in blood tests and vitamin D availability where it actually matters—inside your immune cells and tissues.
Here's the key point: immune cells have their own machinery to activate vitamin D locally, and they need adequate raw material (the storage form, 25-hydroxyvitamin D) to do this. Your blood test might show acceptable levels of activated vitamin D, but if the storage form is too low, your immune cells can't make enough active vitamin D where they need it most.
This tissue-level insufficiency perpetuates inflammation through multiple mechanisms -  it impairs cellular clean-up processes (autophagy), reduces your body's natural antimicrobial defences, and compromises immune tolerance. The clinical result is the patient whose inflammatory markers and symptoms persist despite vitamin D levels that appear adequate on standard blood tests.

Blood vitamin D can appear normal while immune tissues remain functionally deficient. Optimising your storage vitamin D (25-hydroxyvitamin D) to higher physiological ranges—typically 100–150 nmol/L—ensures your immune cells have adequate raw material to activate vitamin D where they need it.

Inflammation Resolution Failures & Autophagy 
When cortisol fails to switch off NF-κB—the master control switch that turns on inflammatory genes—a cascade of downstream consequences unfolds. Persistent NF-κB activation increases production of a protein complex called the NLRP3 inflammasome, essentially priming your cells to produce more inflammatory signals. Once activated, this inflammasome pumps out inflammatory messengers that amplify inflammation throughout the body.
Critically, inflammasome activation directly blocks autophagy—your cells' internal housekeeping and recycling system. Autophagy is responsible for clearing out damaged cellular components, including broken mitochondria. When autophagy is impaired, dysfunctional mitochondria accumulate, further compromising energy production and itaconate synthesis. This closes the loop - inflammasome activation suppresses cellular clean-up, which allows damaged mitochondria to persist, which maintains cortisol resistance, which fails to restrain inflammasome activation.
Autophagy also directly regulates immune activation—it keeps inflammasomes in check, dials down NF-κB signalling, and prevents excessive immune responses. Loss of autophagy therefore represents a critical junction where energy production, inflammation, and immune regulation all intersect.

Restoring autophagy (cellular clean-up) addresses multiple problems simultaneously—inflammasome regulation, mitochondrial quality control, and inflammatory gene suppression. Time-restricted eating, spermidine-rich foods, and adequate vitamin D all support healthy autophagy.

Immune Consequences of Chronically Elevated Cortisol
Beyond its inflammatory effects, persistently elevated cortisol reshapes the immune landscape in ways that perpetuate dysfunction. Chronic high cortisol causes certain immune cells to die off—specifically Th1 cells and natural killer (NK) cells. These are the very populations responsible for fighting viruses and abnormal cells, including early cancer cells.
Loss of these immune cell populations reduces production of interferon-gamma (IFN-γ), a critical immune signalling molecule. IFN-γ is required for immune cells to activate vitamin D locally—so its deficiency further compromises tissue-level vitamin D and cortisol responsiveness. IFN-γ also works together with vitamin D to activate autophagy—their combined deficiency impairs the cellular clean-up response to infection and stress.
The net effect is a paradoxical immune state: elevated cortisol, poor ability to clear infections, diminished surveillance against abnormal cells, and rising autoimmunity risk. The shift toward Th2 dominance—the branch of immunity associated with allergies—further suppresses autophagy and promotes the allergic and skin-related symptoms common in these patients.

Chronic high cortisol depletes your infection-fighting and cancer-surveillance immune cells, reducing interferon-gamma and creating gaps in immune protection. Supporting these immune populations through vitamin D optimisation, adequate zinc, and addressing chronic infections may help rebalance this system.

The Brain & Nervous System
Inflammation in your body doesn't stay confined to your tissues. Inflammatory signals cross into the brain and activate immune cells there, creating brain inflammation that shifts your nervous system toward 'fight or flight' dominance. This stress-dominant state suppresses the calming vagus nerve, with consequences that extend far beyond just feeling stressed.
The vagus nerve does more than help you relax—it actively puts the brakes on inflammation throughout your body through something called the cholinergic anti-inflammatory pathway. When vagal activity drops, this inflammatory brake releases, allowing immune-driven inflammation to escalate unchecked. At the same time, reduced vagal signalling slows gut movement, setting the stage for bacterial overgrowth in the small intestine (SIBO).
The prefrontal cortex—the thinking and executive part of your brain—contributes significantly to this dynamic. Brain inflammation reduces prefrontal activity, and since about ninety percent of prefrontal output feeds the brainstem centres that control the vagus nerve, prefrontal suppression directly translates to reduced vagal activity. The resulting nervous system imbalance perpetuates both brain and body inflammation while progressively compromising digestive function.
Within the gut, loss of vagal anti-inflammatory signalling increases activation of resident immune cells. Combined with cortisol resistance at the gut lining, inflammatory tone rises within the intestinal wall. Mast cells become more reactive, releasing histamine into both local and whole-body circulation. Histamine itself drives brain inflammation and stress-system activation, creating yet another reinforcing loop.

Restoring vagal tone addresses inflammation, gut motility, and nervous system balance simultaneously. Cold exposure, specific breathing practices, and even gargling can stimulate vagal activation, while addressing brain inflammation through anti-inflammatory nutrition and sleep optimisation supports the brain-vagus connection.

Gut Symptoms and the SIBO Connection
The digestive consequences of this brain-nervous system-immune dysfunction deserve particular attention given how common gut complaints are in affected patients. Impaired vagal signalling disrupts the migrating motor complex (MMC)—the wave-like contractions that sweep residual bacteria from the small intestine between meals. Loss of MMC activity creates conditions that allow bacteria to overgrow, regardless of other antimicrobial treatments.
The inflamed gut lining compounds this problem by producing signals that push immunity toward the allergic (Th2) branch. Beyond its effects on immune balance, this Th2 shift directly suppresses autophagy within gut immune cells, perpetuating bacterial imbalances and impairing clearance of microbial fragments that leak through the compromised gut barrier.
SIBO itself drives whole-body inflammation through bacterial toxins leaking into circulation and triggering inappropriate immune activation. This creates yet another layer in the inflammatory architecture: gut-derived inflammation feeds back to the brain, amplifying brain inflammation and stress-system overdrive, which further impairs the vagal signalling necessary to resolve the intestinal bacterial overgrowth.

SIBO treatment that only addresses bacterial overgrowth without restoring the cleansing waves (MMC function) and vagal tone often produces only temporary improvement. Prokinetic support and nervous system rebalancing are essential for lasting resolution.

Treatment Priorities: Restoring the Terrain
The interconnected nature of these systems suggests that effective treatment must address the underlying terrain rather than targeting isolated symptoms. When a patient presents with high cortisol and persistent inflammation, the clinical priorities shift fundamentally from cortisol suppression toward restoring cellular and metabolic health.
Supporting mitochondrial function emerges as a foundational intervention. This includes optimising nutrients needed for energy production (B vitamins, CoQ10, magnesium), reducing oxidative stress on cellular membranes (antioxidant support, reducing toxin exposure), and removing barriers to efficient energy metabolism. When mitochondrial function improves, itaconate production normalises, and cortisol regains its anti-inflammatory power.
Vitamin D optimisation requires attention to circulating levels sufficient for immune cell activation—typically higher than conventional 'adequate' thresholds. This restores both cortisol receptor expression and the vitamin D–interferon-gamma partnership necessary for effective autophagy.
Protecting and restoring Th1 and NK cell function may require addressing hidden chronic infections, optimising zinc status, and ensuring adequate protein intake for immune cell production. The balance between allergic-type (Th2) and infection-fighting (Th1) immunity should be evaluated and addressed through targeted support where indicated.
Restoring vagal tone and reducing stress-system dominance benefits from both direct vagal stimulation practices and upstream interventions addressing brain inflammation. Sleep optimisation, circadian rhythm restoration, and anti-inflammatory nutrition support both nervous system balance and brain immune regulation.
Finally, addressing gut motility through prokinetic support ensures that antimicrobial and gut-balancing interventions produce lasting results rather than temporary bacterial suppression.
The Integrative Perspective
What emerges from this analysis is a picture of chronic inflammatory illness not as a simple excess of stress hormones or inflammatory signals, but as a systems-level failure of the regulatory mechanisms designed to resolve inflammation and restore balance. The patient with high cortisol and persistent fatigue is not experiencing overactive adrenals—they are experiencing a metabolically depleted system working desperately to control a fire with an extinguisher that no longer functions.
This reframing carries profound implications for treatment. The goal is not to force cortisol downward, but to restore the cellular and systemic terrain that allows cortisol to work effectively. When mitochondrial function recovers, when vitamin D signalling normalises, when autophagy resumes, and when vagal tone returns, cortisol often self-regulates—not because it has been suppressed, but because it is finally able to complete its intended function.
For those struggling with chronic fatigue, autoimmune conditions, persistent gut problems, and treatment-resistant inflammation, these insights offer a roadmap for addressing root causes rather than chasing downstream effects. The terrain, as always, determines the outcome.

References
1. Lampropoulou V, Sergushichev A, Bambouskova M, et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metabolism. 2016;24(1):158-166.
2. Mills EL, Ryan DG, Prag HA, et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature. 2018;556(7699):113-117.
3. Zhang Y, Leung DY, Richers BN, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. Journal of Immunology. 2012;188(5):2127-2135.
4. Xie Y, Wen H, Yan K, et al. Glucocorticoid-induced CREB activation and myostatin expression in C2C12 myotubes involves phosphodiesterase-3/4 signaling. Biochemical and Biophysical Research Communications. 2018;503(3):1836-1842.
5. Szondy Z, Sarang Z, Kiss B, Garabuczi É, Köröskényi K. Anti-inflammatory mechanisms triggered by apoptotic cells during their clearance. Frontiers in Immunology. 2017;8:909.
6. Holick MF. Vitamin D deficiency. New England Journal of Medicine. 2007;357(3):266-281.
7. Hewison M. Vitamin D and immune function: an overview. Proceedings of the Nutrition Society. 2012;71(1):50-61.
8. Shenker BJ, Vitale L, Slots J. Immunosuppressive effects of Prevotella intermedia on in vitro human lymphocyte activation. Infection and Immunity. 1991;59(12):4583-4589.
9. Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex—linking immunity and metabolism. Nature Reviews Endocrinology. 2012;8(12):743-754.
10. Bonaz B, Sinniger V, Pellissier S. The vagus nerve in the neuro-immune axis: implications in the pathology of the gastrointestinal tract. Frontiers in Immunology. 2017;8:1452.
11. Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nature Reviews Immunology. 2019;19(8):477-489.
12. Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nature Reviews Immunology. 2013;13(10):722-737.
13. Pinto-Sanchez MI, Hall GB, Ghajar K, et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology. 2017;153(2):448-459.
14. Quigley EMM. The gut-brain axis and the microbiome: clues to pathophysiology and opportunities for novel management strategies in irritable bowel syndrome (IBS). Journal of Clinical Medicine. 2018;7(1):6.
15. Myhill S, Booth NE, McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. International Journal of Clinical and Experimental Medicine. 2009;2(1):1-16.